Apogee Therapeutics APGE
NASDAQ APGE
$135.07 -0.01 (-0.01%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) EPS (Diluted) (2022 - 2026)

Analysis

Apogee Therapeutics (APGE) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Apogee Therapeutics 10.18 Bn 9.20 Bn - -1.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.14
Mar 31, 2026 -1.06
Dec 31, 2025 -1.14
Sep 30, 2025 -1.11
Jun 30, 2025 -1.13
Mar 31, 2025 -0.95
Dec 31, 2024 -1.22
Sep 30, 2024 -0.86
Jun 30, 2024 -0.60
Mar 31, 2024 -0.64
Dec 31, 2023 -1.27
Sep 30, 2023 -0.51
Jun 30, 2023 -3.78
Mar 31, 2023 -2.51
Dec 31, 2022 -5.69
Sep 30, 2022 -9.46
Jun 30, 2022 -1.45